We are live on ! Find out more
KBC Group

KBC Group Portfolio holdings

AUM $39.9B
1-Year Est. Return 29.7%
This Fund
S&P 500
This Quarter Est. Return
-13.93%
1 Year Est. Return
+29.7%
3 Year Est. Return
+99.77%
5 Year Est. Return
+133.11%
10 Year Est. Return
+496.57%
AUM
$20B
AUM Growth
-$5.25B
Cap. Flow
-$1.13B
Cap. Flow %
-5.62%
Top 10 Hldgs %
21.83%
Holding
1,650
New
389
Increased
426
Reduced
533
Closed
104

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$109M
2
ABBV icon
AbbVie
ABBV
+$68.7M
3
ORCL icon
Oracle
ORCL
+$63.5M
4
KO icon
Coca-Cola
KO
+$54.4M
5
ABT icon
Abbott
ABT
+$52.2M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$112M
2
AAPL icon
Apple
AAPL
+$97.1M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$87.3M
4
NVDA icon
NVIDIA
NVDA
+$66.6M
5
MSFT icon
Microsoft
MSFT
+$63M

Sector Composition

Rank Sector Weight
1 Technology 26.14%
2 Healthcare 21.45%
3 Financials 13.18%
4 Consumer Discretionary 9.11%
5 Consumer Staples 7.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TXG icon
1401
10x Genomics
TXG
$5.88B
$38K ﹤0.01%
850
-5,272
-86% -$274K
WSM icon
1402
Williams-Sonoma
WSM
$27.5B
$38K ﹤0.01%
682
CRSR icon
1403
Corsair Gaming
CRSR
$1.1B
$37K ﹤0.01%
+2,819
New +$46K
HLX icon
1404
Helix Energy Solutions
HLX
$1.34B
$37K ﹤0.01%
+12,092
New +$52.3K
ITOS
1405
DELISTED
iTeos Therapeutics
ITOS
$37K ﹤0.01%
+1,773
New +$42.1K
KOP icon
1406
Koppers
KOP
$946M
$37K ﹤0.01%
+1,615
New +$40.9K
LPG icon
1407
Dorian LPG
LPG
$1.96B
$37K ﹤0.01%
+2,451
New +$38.8K
PETS icon
1408
PetMed Express
PETS
$42.3M
$37K ﹤0.01%
+1,876
New +$41.9K
BLFS icon
1409
BioLife Solutions
BLFS
$1.54B
$36K ﹤0.01%
+2,575
New +$37.8K
CENX icon
1410
Century Aluminum
CENX
$4.22B
$36K ﹤0.01%
4,844
-965
-17% -$15K
OFIX icon
1411
Orthofix Medical
OFIX
$492M
$36K ﹤0.01%
+1,539
New +$44.1K
TG icon
1412
Tredegar Corp
TG
$260M
$36K ﹤0.01%
3,608
-11,884
-77% -$138K
TVRD
1413
Tvardi Therapeutics
TVRD
$20.1M
$36K ﹤0.01%
+109
New +$38.2K
DHC
1414
Diversified Healthcare Trust
DHC
$2.15B
$35K ﹤0.01%
+19,279
New +$44.1K
TDAY
1415
USA Today Co
TDAY
$1.29B
$35K ﹤0.01%
+11,956
New +$45.5K
GPMT
1416
Granite Point Mortgage Trust
GPMT
$63.7M
$35K ﹤0.01%
+3,628
New +$37.1K
HT
1417
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
$35K ﹤0.01%
3,617
-8,990
-71% -$90K
EBIX
1418
DELISTED
Ebix Inc
EBIX
$35K ﹤0.01%
+2,065
New +$57.8K
BVN icon
1419
Compañía de Minas Buenaventura
BVN
$7.68B
$34K ﹤0.01%
+5,205
New +$44.9K
OSPN icon
1420
OneSpan
OSPN
$584M
$34K ﹤0.01%
+2,838
New +$37.4K
SPNT icon
1421
SiriusPoint
SPNT
$3.03B
$34K ﹤0.01%
+6,253
New +$37.5K
EZPW icon
1422
Ezcorp Inc
EZPW
$1.79B
$33K ﹤0.01%
+4,429
New +$32.2K
THRY icon
1423
Thryv Holdings
THRY
$184M
$33K ﹤0.01%
+1,483
New +$38K
ANIP icon
1424
ANI Pharmaceuticals
ANIP
$1.86B
$32K ﹤0.01%
+1,081
New +$31.2K
BOOM icon
1425
DMC Global
BOOM
$111M
$32K ﹤0.01%
+1,784
New +$43.8K

Similar funds

KBC Group's Q2 2022 Portfolio in Review

As of Q2 2022, KBC Group held 1,650 positions worth $20B, down 21% from $25.3B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

KBC Group withdrew a net $1.13B in Q2 2022, closing 104 positions and reducing 533 holdings. Its most notable exit was Cerner Corp, an estimated $17.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.

Against the trend, KBC Group opened a new position in AstraZeneca worth $1.34M.

  • KBC Group's largest Q2 2022 buy was AstraZeneca: 10,181 shares worth $1.34M.
  • KBC Group added most to Merck in Q2 2022, an estimated $109M increase.
  • KBC Group's biggest Q2 2022 reduction was Amazon, cutting an estimated $112M.
  • KBC Group fully exited Cerner Corp in Q2 2022, selling an estimated $17.5M.
  • KBC Group's ten largest holdings make up 22% of its $20B portfolio in Q2 2022.
  • KBC Group opened 389 new positions and closed 104 in Q2 2022.
  • KBC Group's portfolio value fell 21% quarter-over-quarter to $20B.

Based on KBC Group's 13F filing for Q2 2022, filed 26 Jul 2022.